Genotyping Support Services
Closed Solicitation Posted
- Solicitation number
- 75N95026R00006
- Agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541690 Other Scientific and Technical Consulting Services
- PSC
- R499 Support- Professional: Other
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institutes of Health National Institute on Aging (NIA) is soliciting quotations for DNA extraction and multi-gene analysis services from rodent tissue samples under Solicitation Number 75N95026R00006, issued as a Request for Quotation for commercial items. The requirement encompasses DNA extraction and isolation from rodent biological samples, polymerase chain reaction (PCR) assays for up to 150 different genes across more than 200 mouse lines, quality assurance analysis on 1% of weekly samples, and completion of all analyses within 72 hours of sample receipt. Key contractor qualifications include a Genotyping Lab Manager with a B.S. in biological, chemical, or genetic science and five years of assay design experience; a Quality Assurance Manager with a B.S. in science or engineering and five years of data analysis and process validation experience; and a Local Technical Representative with three years of customer service experience. The Government will evaluate proposals based on technical capability, price, and past performance, with technical capability and past performance combined being significantly more important than price. All quotations must be received electronically by 12:00 p.m. Eastern Daylight/Standard Time on Friday, March 20, 2026, submitted to Scott Duernberger (Contract Specialist) and Kelly Dempsey (Contracting Officer) at the NIH.
This acquisition has no set-aside restrictions and is open to all qualified contractors in the commercial marketplace under NAICS code 541690, with a small business size standard of $16.5 million. The Government anticipates awarding an Indefinite Delivery Indefinite Quantity (IDIQ) contract with an ordering period from April 4, 2026 through April 3, 2031, with the contract expected to exceed $150,000. Annual sample processing requirements range from a minimum of 25,200 to a maximum of 37,200 samples, resulting in five-year totals between 126,000 and 186,000 samples. The contractor must provide an online bioinformatics database interfaced with the NIA Progeny Database, supply sample collection and storage materials, store samples for six months post-receipt, and cover all shipping and courier costs with three weekly pickups. Performance will be conducted at the contractor's worksite, and the Government retains unlimited rights to all deliverables and data, with the contractor prohibited from publishing scientific data based on this work.
Notice text
Title: NIA Genotyping Outsourcing Project
(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.201-1, Simplified Procedures as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued.
(ii) The solicitation number is 75N95026R00006 and the solicitation is issued as a request for quotation.
This acquisition is for a commercial item or service and is conducted under the authority of the Federal Acquisition Regulation (FAR) and FAR Part 12—Acquisition of Commercial Items and is expected to exceed the simplified acquisition threshold.
(iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) Number 2025-06, with effective date August 26, 2025.
(iv) The associated NAICS code 541690 and the small business size standard is $16.5 million. This requirement has no set-aside restrictions.
(v) This requirement is for the following service: Deoxyribonucleic acid (DNA) extraction and multi-gene analysis from rodent tissue samples. See attached Statement of Work (SOW) for additional details.
(vi) The Government anticipates award of an Indefinite Delivery Indefinite Quantity contract for this acquisition with an anticipated ordering period of April 4, 2026 through April 3, 2031.
(vii) The provision at FAR 52.252-1, Solicitation Provisions Incorporated by Reference (Feb 1998), applies to this acquisition. This solicitation incorporates one or more solicitation provisions by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. The offeror is cautioned that the listed provisions may include blocks that must be completed by the offeror and submitted with its quotation or offer. In lieu of submitting the full text of those provisions, the offeror may identify the provision by paragraph identifier and provide the appropriate information with its quotation or offer. Also, the full text of a solicitation provision may be accessed electronically at these addresses: https://www.acquisition.gov/browse/index/far https://www.hhs.gov/grants/contracts/contract-policies-regulations/hhsar/index.html
(End of provision)
The following provisions apply to this acquisition and are incorporated by reference:
• FAR 52.204-7, System for Award Management (Oct 2018)
• FAR 52.212-1, Instructions to Offerors-Commercial Items (Nov 2021)
• HHSAR 352.239-73, Electronic and Information Technology Accessibility Notice (December 18, 2015)
The clause at FAR 52.252-2, Clauses Incorporated by Reference (Feb 1998), applies to this acquisition. This contract incorporates one or more clauses by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the full text of a clause may be accessed electronically at these addresses:
https://www.acquisition.gov/browse/index/far https://www.hhs.gov/grants/contracts/contract-policies-regulations/hhsar/index.html
(End of clause)
The following clauses apply to this acquisition and are incorporated by reference:
• FAR 52.204-13, System for Award Management Maintenance (Oct 2018)
• FAR 52.212-4, Contract Terms and Conditions--Commercial Items (Oct 2018). Addendum to this FAR clause applies to this acquisition and is attached.
• FAR 52.217-9, Option to Extend the Term of the Contract (Mar 2000)
• HHSAR 352.239-74, Electronic and Information Technology Accessibility (December 2015)
The following provisions and clauses apply to this acquisition and are incorporated as an attachment.
• FAR 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders-Commercial Items (Jan 2022)
• Invoice Instructions
(viii) The provision at FAR clause 52.212-2, Evaluation-Commercial Items, applies to this acquisition.
(a) The Government will award a contract resulting from this solicitation to the
responsible offeror whose offer conforming to the solicitation will be most advantageous to the Government, price and other factors considered. The following factors shall be used to evaluate offers: (i.) technical capability, (ii.) price, and (iii.) past performance [see FAR 13.106-2(b)(3)].
Technical capability and past performance, when combined, are significantly more important than price.
(b) A written notice of award or acceptance of an offer, mailed or otherwise furnished to the successful offeror within the time for acceptance specified in the offer, shall result in a binding contract without further action by either party. Before the offer’s specified expiration time, the Government may accept an offer (or part of an offer), whether or not there are negotiations after its receipt, unless a written notice of withdrawal is received before award.
(ix) The Offerors to include a completed copy of the provision at FAR clause 52.212-3, Offeror Representations and Certifications-Commercial Items, with its offer.
(x) There are no additional contract requirement(s) or terms and conditions applicable to this acquisition.
(xi) The Defense Priorities and Allocations System (DPAS) are not applicable to this requirement.
(xii) Responses to this solicitation must include clear and convincing evidence of the offeror’s capability of fulfilling the requirement as it relates to the technical evaluation criteria. The price proposal must include the labor categories, an estimate of the number of hours required for each labor category, fully loaded fixed hourly rate or each labor category, breakdown and rationale for other direct costs or materials, and the total amount.
In addition, the vendor Unique Entity Identifier (UEI) and the certification of business size must be included in the response. All Offerors must have an active registration in the System for Award Management (SAM) www.sam.gov.”
All quotations must be received by 12:00 p.m., Eastern Daylight/Standard Time, on Friday, March 20, 2026 and reference Solicitation Number 75N95026R00006. Responses must be submitted electronically to Scott Duernberger, Contract Specialist, scott.duernberger@nih.gov and Kelly Dempsey, Contracting Officer, kelly.dempsey@nih.gov. Fax responses will not be accepted.
(xii) The name and telephone number of the individual to contact for information regarding the solicitation:
Scott Duernberger, Contract Specialist
301-594-0670
Scott.Duernberger@nih.gov
Files
| File | Type | Posted |
|---|---|---|
| Q_A.pdf | ||
| SOW.pdf | ||
| Attachment 3 - Invoicing Instructions.pdf | ||
| Attachment 2 - Commercial Clauses_Final.pdf | ||
| Attachment 1 - CSS - COMPETITIVE_Final.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Solicitation | |
| Genotyping Support Services | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Notice of Intent: Measuring AAV9 vector DNA in mice tissue using qPCR | Office of Logisitics and Acquisition Operations | No set-aside | |
| Amplicon sequencing services | Office of Acquisitions and Grants | No set-aside | |
| NAHLN Diagnostic Testing Services | Marketing and Regulatory Programs Business Services | No set-aside | |
| Metagenomics & transcriptomic services | Office of Acquisitions and Grants | Total Small Business | |
| NOI - A Non-Invasive Prognostic Biomarker - Circul | Office of Logisitics and Acquisition Operations | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity